针对严重哮喘患者2型炎症的生物制剂

{"title":"针对严重哮喘患者2型炎症的生物制剂","authors":"I. Pavord, R. Shrimanker, N. Hanania","doi":"10.1183/2312508X.10024618","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":138650,"journal":{"name":"Severe Asthma","volume":"32 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Biologics targeting type 2 inflammation in severe asthma\",\"authors\":\"I. Pavord, R. Shrimanker, N. Hanania\",\"doi\":\"10.1183/2312508X.10024618\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":138650,\"journal\":{\"name\":\"Severe Asthma\",\"volume\":\"32 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Severe Asthma\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1183/2312508X.10024618\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Severe Asthma","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1183/2312508X.10024618","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}